Cartalax 20mg (Bioregulator) Cartalax is a bioregulatory peptide renowned for its systemic effects, particularly on fibroblasts which play a crucial role in tissue repair and senescence across various body systems including the skin, connective tissues, and kidneys. Recognized primarily for its anti-aging properties, Cartalax enhances cell proliferation, improves cell health, and reduces cellular senescence, effectively rejuvenating older cells and promoting longer-lasting tissue health. Product Usage: Cartalax is designated solely for research purposes. It is intended for in vitro testing and laboratory experiments only. All the information provided on this website is for educational purposes. Introducing this compound into humans or animals is strictly prohibited by law. This product must be handled by licensed, qualified professionals and should not be misused as a drug, food, or cosmetic. Introduction Cartalax is a short peptide known for its significant bioregulatory effects. It targets fibroblasts, which are integral in maintaining the structural integrity of various tissues including cartilage, skin, and blood vessels. The peptide is involved in crucial cellular functions such as cell proliferation and apoptosis, making it a key player in anti-aging and tissue regeneration research. Comprehensive Overview and Research Applications Effects on Skin and Connective Tissues Cartalax has been shown to enhance the proliferation of skin cells and the regeneration of tissues, especially in aging models. It modifies the expression of critical cytokines and signaling molecules, reducing the processes associated with aging and promoting a more youthful cellular environment. Cartalax and Kidney Health Research indicates that Cartalax can stimulate cell renewal in kidney tissues, particularly beneficial in older animals. This regenerative capability is due to its effects on increasing proliferation markers like Ki-67 while decreasing pro-apoptotic signals such as p53.